This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Exec Summary As of February 23, 2025, Doximity (NYSE: DOCS), often dubbed the "LinkedIn for Doctors," has shown remarkable strength in the healthcare stock arena, positioning it as a standout performer this year. For the full fiscal year ending March 31, 2025, the company projects revenue between $564.6 million and $565.6
The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. Digital Health Solutions: Digital health solutions are gaining traction in wound care, enabling remote monitoring, telemedicine consultations, and data-driven decision-making.
Innovative startups in the health IT, medical device, and biotech fields were among the shining stars at the annual Collision conference. In 2025 the conference heads to its new home in Vancouver, BC under its new banner – WebSummit Vancouver. The 2024 conference was held in Toronto, ON for the final time.
Evolution and Benefits of DHTs in Neurology Trials DHTs – like wearables, mobile health apps, and telemedicine platforms – have for example significantly impacted the design and execution of neurology trials. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.
Exec Summary: There are a number of reasons why Chinese HealthTech companies are expanding to Europe and more are likely to in the future: Large and growing market: The European healthtech market is large and growing, with a projected value of $700 billion by 2025.
Here are some of the key attributes they are looking for going into 2025: Technology with Disruptive Potential: Innovative Solutions: Acquirers are keen on technologies that can revolutionise healthcare delivery or patient experience. Scalability: The ability to rapidly scale the technology to a broader market is a crucial factor.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content